drugset / Trial / NCT00938522

Efficacy Study of Cilostazol Loading in Elective Percutaneous Coronary Intervention

NCT00938522

Phase 4 Unknown 400 enrolled Samsung Medical Center
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to investigate the effect of cilostazol loading before planned PCI on major adverse cardiac and cerebrovascular events in patients with coronary artery disease.

Timeline

Start
2009-07
Primary completion
2010-12
Completion
2011-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Cilostazol Small molecule 100 mg

Indications

No indication recorded.